来源：市场资讯 （来源：维科网机器人） 近日，"广东机器人第一股"拓斯达发布公告称，正在筹划发行境外股份（H股）并在香港联合交易所有限公司上市事宜。这 一举措旨在深化其全球化发展战略，提升品牌影响力与核心竞争力，同时更好利用国际资本市场，拓展多元化融资渠道。 公告称，拓斯达正与相关中介机构就本次H股上市的具体推进工作进行商讨，相关细节尚未确定，本次H股上市不会导致公 司控股股东和实际控制人发生变化。 国内安防机器人先驱暴雷 作为一家深耕智能制造近20年的领军企业，拓斯达依托多年技术沉淀，不断打磨以工业机器人、注塑机、数控机床为核心的 智能装备，打造以核心技术驱动的智能硬件平台，实现了从核心零部件、高端装备到智能工厂解决方案的全栈闭环。 2025前三季度，拓斯达实现营业收入16.88亿元，同比下滑24.49%；归母净利润4933.65万元，同比增长446.75%；扣非归母净 利润3580.67万元，同比增长3969.23%。其中，工业机器人及自动化应用系统业务实现营业收入5.45亿元，同比增长2.34%， 毛利率36.67%，同比保持稳定 作为广东省战略性新兴产业集群智能机器人领域"链主"，拓斯达在工业机器人领 ...

长江商报消息 ●长江商报记者 黄聪 持续进行"聚焦产品，收缩项目"战略转型，拓斯达（300607.SZ）业绩已开始逐渐进入收获期，公司也 瞄向了港股。 11月12日晚间，拓斯达发布公告称，公司为深化公司全球化发展战略，提升品牌影响力与核心竞争力， 同时更好利用国际资本市场，拓展多元化融资渠道，正在筹划发行境外股份（H股）并在香港联合交易 所有限公司上市事宜。 2025年前三季度，拓斯达实现营业收入16.88亿元，同比下降24.49%；归母净利润4933.65万元，同比增 长446.74%。公司业绩整体出现回暖。 其中，第三季度，拓斯达营业收入达6.02亿元，同比增长17.58%；归母净利润2060.43万元，同比增长 176.93%。 值得一提的是，9月12日，拓斯达正式对外发布首款人形机器人新品"小拓"，率先应用在注塑领域，正 式进军人形机器人赛道。 拓斯达董事长吴丰礼表示，从单一注塑设备业务到机器人、数控机床、注塑机三大核心集群业务的发 展，如今拓斯达持续深化"AI+制造"战略，正用人形机器人打开柔性制造的市场新空间。 主动调整业务结构 拓斯达成立于2007年，最初生产、售卖注塑机，此后涉足数控机床等领域 ...

Group 1 - China Pacific Insurance's subsidiary, China Pacific Life, reported a cumulative premium income of 241.32 billion yuan for the first ten months, a year-on-year increase of 9.9% [1] - China Pacific Property Insurance, another subsidiary, achieved a cumulative premium income of 173.57 billion yuan, with a year-on-year growth of 0.4% [1] - Nocera Biopharma reported a net loss of 64.41 million yuan for the first three quarters, despite a revenue increase of 59.85% to 1.115 billion yuan [1] Group 2 - Founder Securities received approval from the China Securities Regulatory Commission to issue short-term corporate bonds not exceeding 5 billion yuan [1] - Haicheng Bonda's director plans to reduce his stake by up to 0.97%, equating to 198,400 shares [1] - Yuyuan Group intends to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 8.60 yuan per share [1] Group 3 - Huaren Shuanghe's subsidiary passed the GMP compliance inspection for a specific diabetes medication [4] - Lichong Group received project notifications from three international automotive manufacturers, with expected sales amounting to approximately 1.135 billion yuan [6] - Deyang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [7] Group 4 - Longxin General announced the transfer of its entire stake in a subsidiary for 105.6 million yuan, and also plans to divest another stake for 1 yuan due to poor performance [16] - Kangda New Materials decided to terminate the acquisition of a semiconductor company due to unsatisfactory due diligence progress [17] - Lu'an Environmental reported a 3.28% year-on-year increase in coal sales for October, totaling 3.78 million tons [18] Group 5 - Shanghai Port Group plans to invest 2 billion yuan to establish a new holding company with several state-owned enterprises [20] - Borui Pharmaceutical's new drug for obesity treatment has received clinical trial approval [23] - Silver Dragon Co. has completed the registration of a new energy industry fund focusing on high-growth potential projects [24] Group 6 - Hengrui Medicine received approval for a clinical trial of a prostate cancer drug [11] - Baiji Shenzhou reported a net profit of 1.139 billion yuan for the first three quarters, marking a turnaround from losses [36] - Huasheng Pharmaceutical's special medical food product has received registration certification [60]

拓斯达成立于2007年，通过以工业机器人、五轴联动数控机床、注塑机为核心的智能装备，以及控制、 伺服、视觉三大核心技术，打造以人工智能驱动的智能硬件平台，为制造企业提供智能工厂整体解决方 案。截至2025年9月30日，已在国内设立约30家办事处，海外销售与服务遍及50多个国家和地区，公司 先后在越南、墨西哥成立分公司，在泰国、印度、印尼成立客户服务中心，海外市场竞争力逐步提升。 公司已触达客户超过20万家，累计服务客户超过15000家，包括伯恩光学、华为、 立讯精密、富士康、 华勤技术、 歌尔股份、三星、 康宁、 宁德时代等知名企业。 拓斯达表示，公司正与相关中介机构就本次H股上市的具体推进工作进行商讨，相关细节尚未确定，本 次H股上市不会导致公司控股股东和实际控制人发生变化。 | FOU.LO +0.19 +0.63% | | | 休盘中 11-13 1 | | --- | --- | --- | --- | | 最高: 30.29 | 今开:30.10 | 涨停:36.12 | 成交量:388 | | 最低:29.70 | 昨收:30.10 | 跌停:24.08 | 成交额:1.1 | | 换手:1.17 ...

Focus on Chengtun Mining - Company plans to invest approximately 1.423 billion RMB (19.995 million USD) in its subsidiary Chengtun Gold International through its wholly-owned subsidiary Hongsheng International Resources [1] Focus on Century Huatong - Company intends to repurchase shares worth between 500 million to 1 billion RMB, with a maximum repurchase price of 28.77 RMB per share [2] Focus on ST Zhongdi - Company stock experienced a significant price increase of 153.19% from October 16 to November 12, 2025, leading to a trading suspension for verification starting November 13, 2025 [3] Performance Highlights - BeiGene reported a revenue of 27.595 billion RMB for the first three quarters of 2025, marking a year-on-year growth of 44.2%, with a net profit of 1.139 billion RMB [4] Capital Increase & Restructuring - *ST Lian Stone received court approval for its restructuring plan, entering the execution phase after the termination of the restructuring process [5] Important Matters - Tuosda is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries [6] - North Medical's chairman and president were arrested for criminal charges, but the company's control and operations remain stable [7] - Nanjing Public Utilities is transferring 43.731 million shares, accounting for 7.61% of total shares, to Nanjing Innovation Investment Group for approximately 300 million RMB [8] Company Developments - Kaige Precision Machinery is establishing a joint venture with Zhangjiagang Wuyue Special Materials Technology, with an investment of 1 billion RMB for high-end component projects [9] - Stable Medical is investing approximately 2 billion RMB in a new production base for cotton non-woven fabric [10] - Fuchun Environmental is co-investing 116 million RMB in a combined heat and power project in Hubei [10] - Xingsheng Zhihui is collaborating with Beijing Automotive Group for resource sharing in the new energy vehicle sector [10] Stock Trading Updates - Huazhong Silver's subsidiary is undergoing a year-end maintenance shutdown, expected to last 20 days, with no impact on annual production plans [11] - San Yuan Co. clarified that its seasonal product, milk skin candy, has minimal revenue impact [12] - Chongqing Beer plans to distribute a cash dividend of 1.30 RMB per share, totaling approximately 629 million RMB [12] Stock Suspension - ST Zhongdi's stock is suspended for verification due to significant price fluctuations [15]

Group 1 - The company is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its global development strategy and brand influence [2] - The company is currently discussing specific details of the H-share listing with relevant intermediaries, and the plan will require approval from the board, shareholders, and regulatory bodies [2] - The company reported a revenue of approximately 1.688 billion yuan for the first three quarters of 2025, a year-on-year decrease of 24.49%, while net profit attributable to shareholders was approximately 49.34 million yuan, a year-on-year increase of 446.75% [2] Group 2 - The increase in profit is primarily due to a 12.38% year-on-year increase in product-related business revenue, with a gross margin of 38.74%, up 2.55 percentage points [3] - Financial expenses decreased by 24.62 million yuan during the reporting period due to the upcoming delisting of the company's convertible bonds on December 25, 2024 [3] Group 3 - As of November 12, the company's stock price closed at 30.1 yuan per share, with a decline of 2.15% [4]

拓斯达（300607）(300607.SZ)发布公告，公司为深化公司全球化发展战略，提升品牌影响力与核心竞 争力，同时更好利用国际资本市场，拓展多元化融资渠道，正在筹划发行境外股份(H股)并在香港联合 交易所有限公司上市事宜。 ...

智通财经APP讯，拓斯达(300607.SZ)发布公告，公司为深化公司全球化发展战略，提升品牌影响力与核 心竞争力，同时更好利用国际资本市场，拓展多元化融资渠道，正在筹划发行境外股份(H股)并在香港 联合交易所有限公司上市事宜。 ...

Core Viewpoint - The company, Tuosida (300607), is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries regarding the specifics of the H-share listing [1] Group 1 - The company announced on November 12 that it is in the process of planning the issuance of H-shares [1] - The details of the H-share listing are not yet finalized [1]

Core Viewpoint - The company, Tuosida (300607.SZ), is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its global development strategy, brand influence, and core competitiveness while expanding financing channels through international capital markets [1] Group 1 - The specific details of the H-share issuance are not yet determined [1] - The proposed action will not result in changes to the company's controlling shareholder or actual controller [1] - The H-share listing plan will require approval from the company's board of directors, shareholders, and relevant government and regulatory agencies [1]